The biological activity of Zeise's salt and its derivatives

Angew Chem Int Ed Engl. 2015 Feb 23;54(9):2834-7. doi: 10.1002/anie.201410357. Epub 2015 Jan 21.

Abstract

With the aim to design new biologically active bioinorganic drugs of aspirin, whose mode of action is based on the inhibition of the cyclooxygenase(COX) enzymes, derivatives of Zeise's salt were synthesized in this structure-activity relationship study. Surprisingly, not only these Zeise-aspirin compounds but also Zeise's salt itself showed high inhibitory potency against COX enzymes in in vitro assays. In contrast, potassium tetrachloroplatinate and cisplatin did not influence the enzyme activity at equimolar concentrations. It was demonstrated by LC-ESI tandem-mass spectrometry that Zeise's salt platinates the essential amino acids Tyr385 (active site of the enzyme) and Ser516 (will be acetylated by aspirin) of COX-1, thereby strongly impairing the function of the enzyme. This finding demonstrates for the first time that Zeise's salt is pharmacologically active and is a potent enzyme inhibitor.

Keywords: COX inhibition; Zeise’s salt; cellular distribution; cytotoxicity; stability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / analogs & derivatives*
  • Aspirin / chemistry
  • Aspirin / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cyclooxygenase 1 / metabolism*
  • Cyclooxygenase Inhibitors / chemical synthesis
  • Cyclooxygenase Inhibitors / chemistry*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Humans
  • MCF-7 Cells
  • Models, Molecular
  • Molecular Structure
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacology*
  • Salts / chemistry*
  • Structure-Activity Relationship

Substances

  • Cyclooxygenase Inhibitors
  • Organoplatinum Compounds
  • Salts
  • Cyclooxygenase 1
  • Aspirin